265 related articles for article (PubMed ID: 32223511)
1. Catastrophic antiphospholipid syndrome following the introduction of rivaroxaban.
Stammler R; Legendre P; Cacoub P; Blanche P; Piette JC; Costedoat-Chalumeau N
Lupus; 2020 Jun; 29(7):787-790. PubMed ID: 32223511
[TBL] [Abstract][Full Text] [Related]
2. [Seronegative antiphospholipid syndrome, catastrophic syndrome, new anticoagulants: learning from a difficult case report].
Joalland F; de Boysson H; Darnige L; Johnson A; Jeanjean C; Cheze S; Augustin A; Auzary C; Geffray L
Rev Med Interne; 2014 Nov; 35(11):752-6. PubMed ID: 25217794
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants: an alternative treatment for thrombotic antiphospholipid syndrome?
Resseguier AS; Pereira B; Rieu V; Le Guenno G; Grobost V; Ruivard M
Lupus; 2017 Oct; 26(12):1297-1303. PubMed ID: 28355988
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic events in patients with antiphospholipid syndrome treated with rivaroxaban: a series of eight cases.
Signorelli F; Nogueira F; Domingues V; Mariz HA; Levy RA
Clin Rheumatol; 2016 Mar; 35(3):801-5. PubMed ID: 26219490
[TBL] [Abstract][Full Text] [Related]
5. Catastrophic antiphospholipid syndrome: Lessons from 14 cases successfully treated in a single center. A narrative report.
Ruffatti A; De Silvestro G; Marson P; Tonello M; Calligaro A; Favaro M; Del Ross T; Hoxha A; Mattia E; Pengo V
J Autoimmun; 2018 Sep; 93():124-130. PubMed ID: 30146007
[TBL] [Abstract][Full Text] [Related]
6. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
7. After failure with acenocoumarol, rivaroxaban in antiphospholipid syndrome: A report of 2 cases.
Mateos Rodríguez JJ; Bellido D; Castro D; Portillo Sánchez J; Vanegas R; Núñez García A
Reumatol Clin (Engl Ed); 2019; 15(5):e33-e35. PubMed ID: 28546102
[TBL] [Abstract][Full Text] [Related]
8. Catastrophic antiphospholipid syndrome presenting as fever of unknown origin.
Al-Beladi FI
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):110-3. PubMed ID: 22237230
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Thrombosis in Patients with Antiphospholipid Syndrome Receiving Newer Oral Anticoagulants: A Case Report and Review of Literature.
Joshi A; Hong J; Siva C
Clin Med Res; 2017 Jun; 15(1-2):41-44. PubMed ID: 28751467
[TBL] [Abstract][Full Text] [Related]
10. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms.
Erkan D; Espinosa G; Cervera R
Autoimmun Rev; 2010 Dec; 10(2):74-9. PubMed ID: 20696282
[TBL] [Abstract][Full Text] [Related]
11. Diagnostics and treatment of thrombotic antiphospholipid syndrome (APS): A personal perspective.
Pengo V; Denas G
Thromb Res; 2018 Sep; 169():35-40. PubMed ID: 30007134
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic antiphospholipid syndrome: A practical guide to diagnosis and management.
Sayar Z; Moll R; Isenberg D; Cohen H
Thromb Res; 2021 Feb; 198():213-221. PubMed ID: 33485122
[TBL] [Abstract][Full Text] [Related]
13. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Cohen H; Doré CJ; Clawson S; Hunt BJ; Isenberg D; Khamashta M; Muirhead N;
Lupus; 2015 Sep; 24(10):1087-94. PubMed ID: 25940537
[TBL] [Abstract][Full Text] [Related]
14. A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRI.
Rosenbaum AN; Anavekar NS; Ernste FC; Mankad SV; Le RJ; Manocha KK; Barsness GW
Lupus; 2015 Oct; 24(12):1338-41. PubMed ID: 26014099
[TBL] [Abstract][Full Text] [Related]
15. Direct oral anticoagulants versus vitamin K antagonists in antiphospholipid syndrome: A meta-analysis.
Cerdà P; Becattini C; Iriarte A; Hernández JC; Corbella X; Riera-Mestre A
Eur J Intern Med; 2020 Sep; 79():43-50. PubMed ID: 32482595
[TBL] [Abstract][Full Text] [Related]
16. Recurrent thrombosis in patients with antiphospholipid antibodies treated with vitamin K antagonists or rivaroxaban.
Martinelli I; Abbattista M; Bucciarelli P; Tripodi A; Artoni A; Gianniello F; Novembrino C; Peyvandi F
Haematologica; 2018 Jul; 103(7):e315-e317. PubMed ID: 29519861
[No Abstract] [Full Text] [Related]
17. [Catastrophic antiphospholipid syndrome. Presentation of a case].
Díaz Coto JF; Barahona Cuéllar R
Rev Clin Esp; 1995 Jan; 195(1):29-30. PubMed ID: 7878264
[TBL] [Abstract][Full Text] [Related]
18. Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS).
Triplett DA; Asherson RA
Am J Hematol; 2000 Oct; 65(2):154-9. PubMed ID: 10996834
[TBL] [Abstract][Full Text] [Related]
19. Comparing APLS and oranges: caution with the use of direct-acting oral anticoagulants (DOACs) instead of warfarin in the treatment of antiphospholipid syndrome (APLS).
Benger M; Vink J; Snell LB; Breen K
BMJ Case Rep; 2019 Apr; 12(4):. PubMed ID: 30940667
[TBL] [Abstract][Full Text] [Related]
20. Catastrophic antiphospholipid (Asherson's) syndrome.
Cervera R; Asherson RA
Br J Hosp Med (Lond); 2008 Jul; 69(7):384-7. PubMed ID: 18833967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
